Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 180

1.

Bevacizumab (avastin) in ocular processes other than choroidal neovascularization.

Barkmeier AJ, Akduman L.

Ocul Immunol Inflamm. 2009 Mar-Apr;17(2):109-17. doi: 10.1080/09273940802596534. Review.

PMID:
19412873
[PubMed - indexed for MEDLINE]
2.

Twelve-month safety of intravitreal injections of bevacizumab (Avastin): results of the Pan-American Collaborative Retina Study Group (PACORES).

Wu L, Martínez-Castellanos MA, Quiroz-Mercado H, Arevalo JF, Berrocal MH, Farah ME, Maia M, Roca JA, Rodriguez FJ; Pan American Collaborative Retina Group (PACORES).

Graefes Arch Clin Exp Ophthalmol. 2008 Jan;246(1):81-7. Epub 2007 Aug 3.

PMID:
17674014
[PubMed - indexed for MEDLINE]
3.

Rapid improvement of retinal and iris neovascularization after a single intravitreal bevacizumab injection in a patient with central retinal vein occlusion and neovascular glaucoma.

Batioğlu F, Astam N, Ozmert E.

Int Ophthalmol. 2008 Feb;28(1):59-61. Epub 2007 Jul 4.

PMID:
17609852
[PubMed - indexed for MEDLINE]
4.

Bevacizumab in glaucoma: a review.

Ichhpujani P, Ramasubramanian A, Kaushik S, Pandav SS.

Can J Ophthalmol. 2007 Dec;42(6):812-5. Review.

PMID:
18026201
[PubMed - indexed for MEDLINE]
5.

Systemic and ocular safety of intravitreal anti-VEGF therapies for ocular neovascular disease.

Tolentino M.

Surv Ophthalmol. 2011 Mar-Apr;56(2):95-113. doi: 10.1016/j.survophthal.2010.08.006. Review.

PMID:
21335144
[PubMed - indexed for MEDLINE]
6.

Bevacizumab (Avastin) for the treatment of neovascular glaucoma.

Chilov MN, Grigg JR, Playfair TJ.

Clin Experiment Ophthalmol. 2007 Jul;35(5):494-6.

PMID:
17651259
[PubMed - indexed for MEDLINE]
7.

Rebound macular edema following bevacizumab (Avastin) therapy for retinal venous occlusive disease.

Matsumoto Y, Freund KB, Peiretti E, Cooney MJ, Ferrara DC, Yannuzzi LA.

Retina. 2007 Apr-May;27(4):426-31.

PMID:
17420693
[PubMed - indexed for MEDLINE]
8.

Bevacizumab (Avastin) for the treatment of ocular disease.

Gunther JB, Altaweel MM.

Surv Ophthalmol. 2009 May-Jun;54(3):372-400. doi: 10.1016/j.survophthal.2009.02.004. Review.

PMID:
19422965
[PubMed - indexed for MEDLINE]
9.

Intravitreal bevacizumab (Avastin) injection for neovascular glaucoma.

Yazdani S, Hendi K, Pakravan M.

J Glaucoma. 2007 Aug;16(5):437-9.

PMID:
17700285
[PubMed - indexed for MEDLINE]
10.

Intravitreal and intracameral bevacizumab to treat neovascular complications of retinopathy of prematurity.

dell'Omo R, Kulkarni A, Franks WA.

Acta Ophthalmol. 2008 Sep;86(6):698-700. No abstract available.

PMID:
18081905
[PubMed - indexed for MEDLINE]
11.

Intravitreal bevacizumab (avastin) for central and hemicentral retinal vein occlusions: IBeVO study.

Costa RA, Jorge R, Calucci D, Melo LA Jr, Cardillo JA, Scott IU.

Retina. 2007 Feb;27(2):141-9.

PMID:
17290194
[PubMed - indexed for MEDLINE]
12.

Intravitreal bevacizumab for branch retinal vein occlusion.

Spandau U, Wickenhäuser A, Rensch F, Jonas J.

Acta Ophthalmol Scand. 2007 Feb;85(1):118-9. No abstract available.

PMID:
17244225
[PubMed - indexed for MEDLINE]
13.

Adverse events associated with intraocular injections of bevacizumab in eyes with neovascular glaucoma.

Higashide T, Murotani E, Saito Y, Ohkubo S, Sugiyama K.

Graefes Arch Clin Exp Ophthalmol. 2012 Apr;250(4):603-10. doi: 10.1007/s00417-011-1865-8. Epub 2011 Nov 25.

PMID:
22116499
[PubMed - indexed for MEDLINE]
14.

[Indication Avastin in ophthalmology].

Studnicka J.

Cesk Slov Oftalmol. 2010 Nov;66(5):229-33. Czech.

PMID:
21394981
[PubMed - indexed for MEDLINE]
15.

Intravitreal bevacizumab (Avastin) injection in ocular ischemic syndrome.

Amselem L, Montero J, Diaz-Llopis M, Pulido JS, Bakri SJ, Palomares P, Garcia-Delpech S.

Am J Ophthalmol. 2007 Jul;144(1):122-4.

PMID:
17601432
[PubMed - indexed for MEDLINE]
16.

Short-term results of intravitreal bevacizumab (Avastin) on anterior segment neovascularization in neovascular glaucoma.

Silva Paula J, Jorge R, Alves Costa R, Rodrigues Mde L, Scott IU.

Acta Ophthalmol Scand. 2006 Aug;84(4):556-7. No abstract available.

PMID:
16879583
[PubMed - indexed for MEDLINE]
17.

Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusion.

Rabena MD, Pieramici DJ, Castellarin AA, Nasir MA, Avery RL.

Retina. 2007 Apr-May;27(4):419-25.

PMID:
17420692
[PubMed - indexed for MEDLINE]
18.

Retinal sensitivity after intravitreal injection of bevacizumab for the treatment of macular edema secondary to retinal vein occlusion.

Yamaike N, Tsujikawa A, Sakamoto A, Ota M, Kotera Y, Miyamoto K, Kita M, Yoshimura N.

Retina. 2009 Jun;29(6):757-67. doi: 10.1097/IAE.0b013e31819d4fbf.

PMID:
19289982
[PubMed - indexed for MEDLINE]
19.

[Intravitreal anti-VEGF therapy with bevacizumab for neovascular AMD].

Schaal KB, Engler C, Schütt F, Scheuerle A, Dithmar S.

Ophthalmologe. 2008 Jun;105(6):538-43. doi: 10.1007/s00347-007-1638-2. German.

PMID:
18299845
[PubMed - indexed for MEDLINE]
20.

Bevacizumab local complications.

Gordon-Angelozzi M, Velez-Montoya R, Fromow-Guerra J, García-Aguirre G, Guerrero-Naranjo JL, Quiroz-Mercado H, Morales-Cantón V.

Ophthalmology. 2009 Nov;116(11):2264.e1-3. doi: 10.1016/j.ophtha.2009.07.027. No abstract available.

PMID:
19883862
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk